- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02711319
Non-invasive Brain Stimulation for Gait Improvement in Patients With Spinal Cord Injury (SCI)
Non-invasive Brain Stimulation in SCI
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive and painless procedure to modulate cortical excitability of motor areas and induce changes over the descending corticospinal output. This modulation may be useful to promote active recovery of motor function and to obtain functional benefit from gait rehabilitation. Through the use of repetitive high-frequency rTMS, improvement has been reported in motor and sensory functions measured by American Spinal Cord Injury Association (ASIA) Impairment Scale (AIS), and time to complete a peg-board task in four chronic incomplete cervical SCI patients.
Physical therapy aims to improve function of both undamaged and also, as far as possible, damaged neuronal structures. However, 'reorganization' of neuronal circuits is the target of specific training approaches. Therefore, the challenge is to guide CNS plasticity in order to optimize the functional outcome for a given individual. Hypothesized was that high-frequency rTMS coupled with gait training can improve motor recovery in the lower extremities and locomotion in incomplete SCI patients to a greater degree than sham stimulation.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
inclusion criteria:
- had subacute motor incomplete SCI (AIS-C or D),
- candidate for gait rehabilitation with Lokomat® after cervical or thoracic SCI;
- stable medical treatment at least one week before and during the study;
- without limitation of passive range of movement in joints
- agreed to participate after signing a written informed consent form.
exclusion criteria:
- unstable clinical state
- severe spasticity (MAS>=3)
- disagreed to sign consent form
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: active (real) rTMS (ACTIVE GROUP)
The patients were randomly distributed in two study groups: real or sham rTMS group. For real rTMS, we applied 2 seconds duration bursts of 20 Hz (40 pulses/burst) with intertrain intervals of 28 seconds, for a total of 1800 pulses over 20 minutes. |
For real (active) rTMS, we applied 2 seconds duration bursts of 20 Hz (40 pulses/burst) with intertrain intervals of 28 seconds, for a total of 1800 pulses over 20 minutes
Other Names:
|
Sham Comparator: sham rTMS (SHAM GROUP)
For sham rTMS, the double cone coil was again held over the vertex, but it was disconnected from the main stimulator unit.
Instead, a second coil (8-shaped) was connected to the MagStim stimulator, and discharged under the patient's pillow (2).
|
Sham Comparator: sham rTMS (SHAM GROUP) For sham rTMS, the double cone coil was again held over the vertex, but it was disconnected from the main stimulator unit. Instead, a second coil (8-shaped) was connected to the MagStim stimulator, and discharged under the patient's pillow (2).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ten-meters walking test (10MWT=Time in seconds to walk 10 meters.)
Time Frame: Change from Baseline 10MWT at 4 and 8 weeks
|
Patients with or without orthesis were asked to walk at their fastest but most comfortable speed and step length and cadence assessed during the 10MWT (We added the number of steps taken in 10 m.
Step length (meters)=distance (m) x 2 / number of stops (heel to heel of same foot).
Cadence (steps/min.)=number of steps x 60 / time (seconds))
|
Change from Baseline 10MWT at 4 and 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Modified Ashworth Scale (MAS)
Time Frame: Change from Baseline MAS at 4 weeks
|
Tests resistance to passive movement about a joint with varying degrees of velocity at knees
|
Change from Baseline MAS at 4 weeks
|
--Total motor score from upper (UEMS) and lower extremities (LEMS)
Time Frame: Change from Baseline 1UEMS and LEMS at 4 and 8 weeks
|
Total motor score from upper (UEMS) (score 50points) and lower extremities (LEMS) (score 50points) obtained from the standardized AIS clinical exam (total score=100)
|
Change from Baseline 1UEMS and LEMS at 4 and 8 weeks
|
Walking Index for SCI (WISCI) II
Time Frame: Change from Baseline WISCI-II at 4 and 8 weeks
|
The ranking of severity of gait is based on the severity of the impairment and not on functional independence in the environment.
|
Change from Baseline WISCI-II at 4 and 8 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PI10/00442
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Functional Improvement
-
Federal University of Health Science of Porto AlegreCompletedEffect of a Program of Deep Inspiration Combined to Expiratory Positive Airway Pressure in AsthmaticImprovement of Functional Capacity. | Improvement of Quality of Life. | Improvement of Cardiovascular Autonomic Control.Brazil
-
Federal University of Health Science of Porto AlegreInstituto de Cardiologia do Rio Grande do Sul; Coordenação de Aperfeiçoamento...UnknownImprovement of Functional Capacity. | Improvement of Quality of Life. | Improvement of Cardiovascular Autonomic Control. | Reduction of Blood Pressure in Hypertensive Patients.Brazil
-
VascuScript PharmacyCommunity Pharmacy FoundationCompletedMedication Adherence | Health Literacy | Geriatric Patient Care Improvement | Pharmacy Economic ImprovementUnited States
-
NestléCompletedImprovement of FunctionalitySwitzerland
-
Deborah Yurgelun-ToddCompletedNeurocognitive ImprovementUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
US Department of Veterans AffairsCompletedQuality ImprovementUnited States
-
Liverpool University Hospitals NHS Foundation TrustNot yet recruitingMedical Education | Quality ImprovementUnited Kingdom
-
Institute for Clinical Effectiveness and Health...Ministry of Public Health, ArgentinaCompletedCardiovascular Diseases | Quality ImprovementArgentina
-
West Virginia UniversityWithdrawn
Clinical Trials on rTMS
-
Chang Gung Memorial HospitalMinistry of Science and Technology, TaiwanRecruiting
-
Chang Gung Memorial HospitalRecruiting
-
Changping LaboratoryBeijing HuiLongGuan HospitalRecruitingMajor Depressive Disorder | Severe Depression | Moderate DepressionChina
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Centre hospitalier de Ville-Evrard, FranceRecruitingTo Evaluate the Effectiveness of Open rTMSFrance
-
Stanford UniversityRecruitingMajor Depressive DisorderUnited States
-
Bayside HealthCompletedAutistic Disorder | Asperger's DisorderAustralia
-
Changping LaboratoryWuhan Mental Health CentreRecruitingMajor Depressive Disorder | Severe Depression | Moderate DepressionChina
-
Prof. Dominique de Quervain, MDRecruiting